Stock profit

Kangtai Biological’s first-quarter profit surged 11x on strong sales

By Gilberto S. Lopez






Newswires MT 2022

All news about SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.

Sales 2021 4,474 million
702M
702M
Net income 2021 1,600 million
251M
251M
Net cash 2021 2,545 million
399M
399M
PER 2021 ratio 37.8x
2021 performance 0.47%
Capitalization 55,306M
8,673 million
8,673 million
EV / Sales 2021 11.8x
EV / Sales 2022 9.27x
# of employees 2,043
Floating 44.9%

Chart SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.


Duration :

Period :




Shenzhen Kangtai Biological Products Co., Ltd. Technical Analysis Chart | MarketScreener

Trends in Technical Analysis SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.

Short term Middle term Long term
Tendencies Bullish Neutral Bearish



Evolution of the income statement

To sell

To buy
Medium consensus TO BUY
Number of analysts 7
Last closing price 80.50 yuan
Average target price CNY129.74
Average Spread / Target 61.2%


Related posts:

  1. Siemens Gamesa replaces CEO after three profit warnings By Reuters
  2. Cognex shares rise on record profit and revenue in 2021
  3. General Electric shares slide on bid, Labor hits 2022 earnings
  4. Intel and NEP: Ways to Profit Even When Stocks Go Down
Gilberto S. Lopez
You might also like More from author

Comments are closed.